Back to All Events

2026 Best of ASCO® Boston


  • Hyatt Regency Boston One Avenue De Lafayette Boston, MA, 02111 (map)

In-Person Access Only | 8.0 CE/CME Credits & MOC Points

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health's 2026 Best of ASCO® Boston Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Program Chairs:
Thierry Alcindor, MD, MSc (Dana-Farber Cancer Institute)
Beverly Moy, MD, MPH (Massachusetts General Hospital)

Conference Agenda
Saturday, August 8, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Welcome and Opening Remarks
Thierry Alcindor, MD, MSc | Dana-Farber Cancer Institute

8:40 AM
Colorectal Cancer
Daniel Lin, MD | Thomas Jefferson University

9:10 AM
Non-Colorectal Cancer

Bruno Bockorny, MD, FACP | Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast presented by Regeneron - Immunotherapy in Practice: A Compelling Case-Based Discussion Examining Actual Patients with Advanced NSCLC
Mohamed Mohamed, MD, PHD | Cone Health Cancer Center at Wesley Long, Moses H. Cone Memorial Hospital


10:40 AM
Prostate Cancer
Kathleen Mahoney, MD | Beth Israel Deaconess Medical Center

11:10 AM
Non-Prostate Cancer

Brad McGregor, MD | Dana-Farber Cancer Institute‍ ‍

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch presented by Incyte - Monjuvi + Rituximab & Lenalidomide: The First and Only CD19- and CD20-targeted Immunotherapy Combination for 2L+ Follicular Lymphoma Patients
Charles Farber, MD | Carol G. Simon Cancer Center

12:40 PM
Housekeeping and Survey

12:50 PM
Leukemia

Courtney DiNardo, MD, MSCE | MD Anderson

1:20 PM
Lymphoma
Henry Fung, MD | Fox Chase Cancer Center -Temple Health

1:50 PM
Head and Neck Cancer
Nabil Saba, MD, FACP | Emory University


2:20 PM
Sarcomas and Rare Cancers
Thierry Alcindor, MD, MSc | Dana-Farber Cancer Institute

2:50 PM
Adjourn

Sunday, August 9, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Welcome and Opening Remarks
Beverly Moy, MD, MPH | Massachusetts General Hospital

8:40 AM
Small Cell Lung Cancer

Pasi Jänne, MD, PhD|Dana-Farber Cancer Institute

9:10 AM
Non-Small Cell Lung Cancer
‍ ‍
Ana Velázquez Mañana, MD, MSc, FASCO | University of California, San Francisco ‍ ‍
‍ ‍‍ ‍
9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast presented by Pfizer

10:40 AM
Multiple Myeloma
Philip McCarthy, MD | Roswell Park Comprehensive Cancer Center

11:10 AM
Melanoma
Ryan Sullivan, MD | Massachusetts General Hospital

11:40 AM
Gynecological Oncology
Ramez Eskander, MD | Moores Cancer Center

12:10 PM

Lunch and Exhibits

12:25 PM
Non-CME Lunch presented by AbbVie - Non-CME Lunch - Abbvie - A Case-Based Approach to Collaborative BCL2-Inhibitor Management in AML

Melissa Laramie | AbbVie
Evgeny Mikler | AbbVie

1:10 PM
Survivorship
Stacy Wentworth, MD | Duke University School of Medicine‍ ‍

1:40 PM
Early-Stage Breast Cancer
Beverly Moy, MD, MPH | Massachusetts General Hospital

2:10 PM
Metastatic Breast Cancer

Adrienne Waks, MD | Dana-Farber Cancer Institute‍ ‍

2:40 PM
Adjourn

Agenda Subject To Change. All times are EST.

 
 
Previous
Previous
August 1

2026 Best of ASCO® Minneapolis

Next
Next
August 8

2026 Best of ASCO® Memphis